NM_000722.4:c.3266G>T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000722.4(CACNA2D1):c.3266G>T(p.Arg1089Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,612,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000722.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D1 | ENST00000356860.8 | c.3266G>T | p.Arg1089Leu | missense_variant | Exon 39 of 39 | 1 | NM_000722.4 | ENSP00000349320.3 | ||
CACNA2D1 | ENST00000443883.2 | c.3302G>T | p.Arg1101Leu | missense_variant | Exon 39 of 39 | 5 | ENSP00000409374.2 | |||
CACNA2D1 | ENST00000705962.1 | c.3146G>T | p.Arg1049Leu | missense_variant | Exon 38 of 38 | ENSP00000516190.1 | ||||
CACNA2D1 | ENST00000705961.1 | c.3032G>T | p.Arg1011Leu | missense_variant | Exon 37 of 37 | ENSP00000516189.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151762Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250926Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135598
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461168Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 726890
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151762Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74074
ClinVar
Submissions by phenotype
Brugada syndrome Uncertain:1
This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 1089 of the CACNA2D1 protein (p.Arg1089Leu). This variant is present in population databases (rs143631985, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with CACNA2D1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1519635). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.R1089L variant (also known as c.3266G>T), located in coding exon 39 of the CACNA2D1 gene, results from a G to T substitution at nucleotide position 3266. The arginine at codon 1089 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at